Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14504 | 699 | 37.3 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
701 | 12232 | RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EP CAM | Author keyword | 90 | 47% | 20% | 141 |
2 | TROP2 | Author keyword | 36 | 79% | 3% | 23 |
3 | EDRECOLOMAB | Author keyword | 14 | 100% | 1% | 7 |
4 | GA733 2 | Author keyword | 13 | 71% | 1% | 10 |
5 | TROP 2 | Author keyword | 12 | 63% | 2% | 12 |
6 | MT201 | Author keyword | 12 | 86% | 1% | 6 |
7 | MK 1 | Author keyword | 9 | 67% | 1% | 8 |
8 | ADECATUMUMAB | Author keyword | 8 | 75% | 1% | 6 |
9 | EPITHELIAL CELL ADHESION MOLECULE | Author keyword | 8 | 35% | 3% | 18 |
10 | HRS7 | Author keyword | 6 | 80% | 1% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EP CAM | 90 | 47% | 20% | 141 | Search EP+CAM | Search EP+CAM |
2 | TROP2 | 36 | 79% | 3% | 23 | Search TROP2 | Search TROP2 |
3 | EDRECOLOMAB | 14 | 100% | 1% | 7 | Search EDRECOLOMAB | Search EDRECOLOMAB |
4 | GA733 2 | 13 | 71% | 1% | 10 | Search GA733+2 | Search GA733+2 |
5 | TROP 2 | 12 | 63% | 2% | 12 | Search TROP+2 | Search TROP+2 |
6 | MT201 | 12 | 86% | 1% | 6 | Search MT201 | Search MT201 |
7 | MK 1 | 9 | 67% | 1% | 8 | Search MK+1 | Search MK+1 |
8 | ADECATUMUMAB | 8 | 75% | 1% | 6 | Search ADECATUMUMAB | Search ADECATUMUMAB |
9 | EPITHELIAL CELL ADHESION MOLECULE | 8 | 35% | 3% | 18 | Search EPITHELIAL+CELL+ADHESION+MOLECULE | Search EPITHELIAL+CELL+ADHESION+MOLECULE |
10 | HRS7 | 6 | 80% | 1% | 4 | Search HRS7 | Search HRS7 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EP CAM | 113 | 45% | 27% | 192 |
2 | ANTIGEN EPCAM | 79 | 79% | 7% | 50 |
3 | MAB 17 1A | 31 | 92% | 2% | 12 |
4 | 17 1A | 26 | 56% | 5% | 32 |
5 | EP CAM EXPRESSION | 25 | 70% | 3% | 21 |
6 | ANTIGEN EP CAM | 24 | 91% | 1% | 10 |
7 | CALCIUM SIGNAL TRANSDUCER | 21 | 90% | 1% | 9 |
8 | IMMUNOTHERAPEUTIC TARGET | 12 | 75% | 1% | 9 |
9 | KS1 4 | 12 | 86% | 1% | 6 |
10 | EPCAM EXPRESSION | 11 | 67% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review | 2012 | 87 | 45 | 56% |
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule | 2007 | 186 | 70 | 66% |
EpCAM in carcinogenesis: the good, the bad or the ugly | 2010 | 94 | 96 | 60% |
The biology of the 17-1A antigen (Ep-CAM) | 1999 | 321 | 49 | 53% |
EpCAM and the biology of hepatic stem/progenitor cells | 2015 | 1 | 140 | 41% |
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling | 2009 | 157 | 17 | 65% |
EpCAM: Structure and function in health and disease | 2013 | 15 | 141 | 50% |
Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy | 2013 | 20 | 128 | 37% |
EpCAM - A new therapeutic target for an old cancer antigen | 2003 | 80 | 53 | 57% |
The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology | 2003 | 112 | 72 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT CANC PATHOL | 4 | 36% | 1.4% | 10 |
2 | HEAD NECK SURG PROGRAM | 3 | 60% | 0.4% | 3 |
3 | CLIN COOPERAT GRP MOL ONCOL | 3 | 24% | 1.4% | 10 |
4 | LIFESTOCK IND | 1 | 100% | 0.3% | 2 |
5 | OCULAR ONCOL VITREORETINA | 1 | 50% | 0.3% | 2 |
6 | NANOTHECHNOL | 1 | 40% | 0.3% | 2 |
7 | ALEX SIMONA SHNAIDER MOL ONCOL | 1 | 17% | 0.7% | 5 |
8 | ONCOL RADIUMHEMMET | 1 | 17% | 0.7% | 5 |
9 | SECT MED BIOL | 1 | 12% | 1.0% | 7 |
10 | CANC KAROLINSKAIMMUNE GENE THER Y | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000153856 | BISPECIFIC ANTIBODIES//CATUMAXOMAB//TRIFUNCTIONAL ANTIBODY |
2 | 0.0000146848 | ANTI IDIOTYPIC ANTIBODY//ANTI ANTI IDIOTYPIC ANTIBODY//INTERNAL IMAGE |
3 | 0.0000112028 | UNIT OTOLARYNGOL HEAD NECK SURG//E48//BIOMED RADIAT |
4 | 0.0000106567 | ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS//RADIOIMMUNOGUIDED SURGERY//IMMUNOSCINTIGRAPHY |
5 | 0.0000101920 | POLYVALENT ANTIGEN//AUTOLOGOUS ANTIBODY//B700 |
6 | 0.0000077405 | MICROVILLOUS INCLUSION DISEASE//AUTOIMMUNE ENTEROPATHY//INTRACTABLE DIARRHEA |
7 | 0.0000076082 | CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//CIRCULATING TUMOUR CELLS |
8 | 0.0000072233 | IMMUNOCYTOKINES//IMMUNOCYTOKINE//PHILOCHEM AG |
9 | 0.0000063858 | 5T4//TUMOR IMMUNOL BIOL//5T4 ONCOFETAL ANTIGEN |
10 | 0.0000062465 | SMALL CELL LUNG CANCER CELL LINE//SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY |